• Dorsomorphin (Compound C): New Insights into AMPK and BMP4 P

  2026-07-22

  Dorsomorphin (Compound C) is a powerful tool for dissecting AMPK and BMP4 signaling in vascular and metabolic contexts. This article uniquely explores its application in endothelial dysfunction models, practical assay design, and emerging translational implications.

• Indomethacin in Inflammation and Lipid Metabolism Research

  2026-07-22

  Indomethacin enables precise interrogation of Cox-1/Cox-2 signaling and PPARγ-driven adipocyte differentiation, making it invaluable for dissecting inflammation and lipid metabolism in complex cellular models. This guide details actionable workflows, advanced troubleshooting, and protocol innovations, leveraging both recent literature and APExBIO’s high-purity offering.

• NMDAR-Dependent Cav2.1 Recruitment in PV Interneuron Maturat

  2026-07-21

  This study reveals that NMDA receptor (NMDAR) signaling is essential for the maturation of GABAergic transmission from neocortical parvalbumin (PV) interneurons via recruitment of Cav2.1 calcium channels. These findings clarify mechanisms underlying excitation/inhibition balance and have significant implications for understanding neurodevelopmental origins of schizophrenia.

• Filipin III: Advanced Cholesterol Detection in Membranes

  2026-07-21

  Filipin III, a polyene macrolide antibiotic from APExBIO, is the benchmark fluorescent probe for membrane cholesterol visualization and quantification. This article details robust protocols, advanced use-cases in immunometabolic research, and troubleshooting strategies that empower researchers to unlock cholesterol-driven cellular mechanisms.

• Targeted mRNA Nanoparticles Restore BBB After Ischemic Strok

  2026-07-20

  This study introduces a targeted lipid nanoparticle (LNP) platform for delivering mRNA encoding interleukin-10 (IL-10) to M2 microglia in the post-ischemic brain. The approach demonstrates robust restoration of the blood-brain barrier (BBB) and improved neurological outcomes by modulating microglial polarization, offering a promising direction for mRNA therapeutics in neuroprotection.

• Isolation and Characterization of Forsythoside E from Forsyt

  2026-07-20

  This study details the isolation and structural elucidation of Forsythoside E and related phenylethanoid glycosides from Forsythia suspensa fruits, employing advanced chromatographic and spectroscopic approaches. The findings establish a chemical foundation for Forsythoside E's subsequent use in mechanistic immunometabolic research.

• Network Pharmacology Uncovers SFI's Anti-Glioma Mechanisms

  2026-07-19

  This study uses network pharmacology and experimental validation to reveal how Shenqi Fuzheng injection (SFI) suppresses glioma cell proliferation and migration, primarily via inhibition of the SRC/PI3K/AKT pathway. These findings clarify the multi-target actions of SFI and provide a mechanistic framework for anti-angiogenic and tumor inhibition research.

• Regorafenib (BAY 73-4506): Applied Workflows in Cancer Biolo

  2026-07-18

  Regorafenib (BAY 73-4506) empowers translational cancer research by precisely targeting angiogenesis and tumor signaling pathways, including RRM2 and ERK/E2F3. This article guides you through validated experimental workflows, protocol optimizations, and troubleshooting strategies to accelerate impactful discoveries in cancer biology.

• Gli1+ Progenitors Drive Glucocorticoid-Induced Osteoporosis

  2026-07-17

  This study uncovers how Gli1+ metaphyseal mesenchymal progenitors (MMPs) are central mediators of glucocorticoid-induced osteoporosis, using in vivo lineage tracing and single-cell RNA sequencing. The findings advance understanding of cell-specific vulnerabilities in bone loss, offering new directions for targeted therapeutic intervention.

• Irinotecan (CPT-11): Optimized Workflows in Colorectal Cance

  2026-07-17

  Irinotecan (CPT-11) empowers researchers to induce DNA damage and apoptosis with precision in colorectal cancer models. This guide details advanced protocols, troubleshooting strategies, and translational applications that set APExBIO's Irinotecan apart for rigorous preclinical investigation.

• BMS-777607: Transforming MET Signaling for Translational Res

  2026-07-16

  This thought-leadership article explores the dual power of BMS-777607, a highly selective c-Met inhibitor from APExBIO, in advancing both cancer metastasis models and the next generation of hiPSC-derived platelet protocols. Integrating mechanistic insight with strategic workflow guidance, the piece draws on recent evidence and protocol innovations to offer translational researchers actionable intelligence and a future-focused perspective.

• Anti Reverse Cap Analog: Elevating Synthetic mRNA Translatio

  2026-07-16

  Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, transforms synthetic mRNA workflows with orientation-specific capping that doubles translational efficiency and boosts mRNA stability. Discover actionable protocols, troubleshooting strategies, and translational use-cases for maximizing mRNA therapeutics and cell reprogramming success.

• Hoechst 33342 Nuclear Stain: Precision for Live and Fixed Ce

  2026-07-15

  Hoechst 33342 Solution (1 mg/mL) sets the standard for high-fidelity nuclear visualization in both live and fixed cell assays. Its superior membrane permeability, low cytotoxicity, and compatibility with advanced workflows make it indispensable for mechanistic studies of cell senescence and mitochondrial quality.

• IPR-803: Advancing uPAR Inhibition in Translational Oncology

  2026-07-15

  This article explores IPR-803, a cutting-edge urokinase receptor inhibitor, through the lens of mechanistic rationale, experimental validation, and strategic translational applications. Drawing from recent literature and product intelligence, it provides actionable guidance for researchers targeting tumor invasion and metastasis, with an emphasis on breast and pancreatic cancer models.

• Pioglitazone as a PPARγ Agonist: Experimental Workflows & In

  2026-07-14

  Pioglitazone, a benchmark PPARγ agonist, empowers researchers to dissect immunometabolic and inflammatory mechanisms with high specificity and translational value. This guide details cutting-edge workflows, practical troubleshooting, and actionable protocol enhancements grounded in recent advances—enabling robust, reproducible studies across metabolic and neuroinflammatory disease models.

16220 records 1/1082 page Next 12345 下5页 Last page